Influenza Diagnostics Market Segmentation Forecast to 2023 by Key Players Roche Diagnostics, Meridian Bioscience Inc., Becton, Abbott, QIAGEN, Alere Inc., Thermo Fisher Scientific Inc., and Dickinson & Company

The Influenza Diagnostics Market is expected to reach approximately USD 0.88 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 8.45% during the forecast period. Influenza or popularly known as ‘Flu’ is an infectious disease that is caused by any virus of influenza. Due to rising incidences of influenza the influenza diagnostic market is experiencing a growth in volume as well as value. The development in Investments for flu diagnostics, and rising interest for quicker diagnostics of influenza and control of flu are the central factors that are relied upon to drive the development of this market in the forecast years.

Get Free Sample Copy@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54653

Test Type Outlook and Trend Analysis

According to the Type the market of Influenza Diagnostics is divided into Traditional and Molecular. The Traditional Test type is further divided into Traditional Viral Culture, Serology Test, Rapid Influenza Detection Test, and DFA. Rapid Influenza Detection Test (RIDT) constituted the major share of the market due to its benefits such as quick results, user friendly, etc. The RIDT is expected to continue growing during the forecast period. The Molecular test types segment is also further divided into Nucleic Acid Sequence-Based Amplification (NASBA), RT-PCR, Loop-Mediated Isothermal Amplification-Based Assays (LAMP), and Simple Amplification-Based Assays (SAMBA). Due to its ability to distinguish between Influenza A & B viruses the RT-PCR is the most widely used Molecular test.

End User Method Outlook and Trend Analysis

The End-User segment is fragmented into Hospitals & Clinics, Reference lab, POC, Home Care Agency. The Hospitals and Clinics segments amongst the End-User segments are prominent due to extensive use of these tests in diagnostics of influenza which are mostly carried out there.

Make an enquiry before buying this Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54653

Regional Outlook and Trend Analysis

According to the region, the Influenza Diagnostics Market is segmented as North America, Asia-Pacific, Europe and South America and Middle East & Africa. The Europe regions accounts to the majority of the share in the Influenza Diagnostics Market due to increasing population and also rising incidents of influenza diseases. The North-America region is the second largest market for Influenza Diagnostics followed by Asia-Pacific which is expected to grow at the highest CAGR during the forecast owing to increased expenditure, rising influenza incidents, etc.

Competitive Insights

The leading players in the market are Roche Diagnostics, Meridian Bioscience Inc., Becton, Abbott, QIAGEN, Alere Inc., Thermo Fisher Scientific Inc., and Dickinson & Company. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Influenza Diagnostics Market is segmented as follows-

By Natural Test Type:

Traditional Viral Culture
Serology Test
Rapid Influenza Detection Test
DFA

Purchase Direct Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-CMR-HnM-54653/

By Molecular Test Type:

Nucleic Acid Sequence-Based Amplification (NASBA)
RT-PCR
Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
Simple Amplification-Based Assays (SAMBA)

By End User:

Hospital
Clinic
Reference lab
POC
Home Care Agency

By Region

North America

U.S.
Canada
Mexico

Europe
Germany
UK
France
Russia
Italy
Rest of Europe

Asia-Pacific

China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific

South America

Brazil
Argentina
Columbia
South Africa
Rest of South America

Middle East and Africa

Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA

About Us:
Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Contact Us:
Nehal Chinoy
Runwal Platinum,
Ramnagar Colony, Bavdhan,
Pune, Maharashtra, India-411021
IN +919881074592
info@qurateresearch.com
https://www.qurateresearch.com/

This release was published on openPR.